JPMorgan Chase & Co. Has Lowered Expectations for Procter & Gamble (NYSE:PG) Stock Price

Procter & Gamble (NYSE:PG) had its price target decreased by equities research analysts at JPMorgan Chase & Co. from $164.00 to $162.00 in a research report issued to clients and investors on Thursday,Benzinga reports. The brokerage currently has an “overweight” rating on the stock. JPMorgan Chase & Co.‘s price objective would indicate a potential upside of 8.11% from the stock’s current price.

Several other research firms also recently issued reports on PG. Wells Fargo & Company raised their price target on shares of Procter & Gamble from $158.00 to $164.00 and gave the company an “overweight” rating in a research note on Monday, April 27th. Sanford C. Bernstein began coverage on Procter & Gamble in a report on Thursday, June 11th. They set a “market perform” rating and a $156.00 target price on the stock. BNP Paribas Exane reduced their price target on Procter & Gamble from $172.00 to $165.00 and set an “outperform” rating on the stock in a research report on Thursday, April 23rd. Weiss Ratings reissued a “hold (c)” rating on shares of Procter & Gamble in a research note on Wednesday, June 24th. Finally, Royal Bank Of Canada lowered their price objective on Procter & Gamble from $172.00 to $167.00 and set an “outperform” rating for the company in a research report on Thursday, April 9th. Twelve analysts have rated the stock with a Buy rating and nine have given a Hold rating to the company’s stock. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of $161.42.

Procter & Gamble Stock Performance

NYSE:PG opened at $149.84 on Thursday. The stock’s 50-day moving average is $146.80 and its 200-day moving average is $148.54. Procter & Gamble has a 1-year low of $137.62 and a 1-year high of $167.25. The company has a current ratio of 0.73, a quick ratio of 0.53 and a debt-to-equity ratio of 0.44. The stock has a market cap of $348.92 billion, a P/E ratio of 21.91, a price-to-earnings-growth ratio of 7.38 and a beta of 0.39.

Procter & Gamble (NYSE:PG) last issued its quarterly earnings data on Friday, April 24th. The company reported $1.59 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.56 by $0.03. Procter & Gamble had a net margin of 19.16% and a return on equity of 32.00%. The business had revenue of $21.23 billion during the quarter, compared to analyst estimates of $21.52 billion. During the same quarter last year, the business earned $1.54 EPS. The firm’s quarterly revenue was up 7.4% on a year-over-year basis. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. Equities research analysts anticipate that Procter & Gamble will post 6.88 earnings per share for the current year.

Institutional Inflows and Outflows

Institutional investors have recently modified their holdings of the stock. Vanguard Group Inc. boosted its holdings in Procter & Gamble by 1.2% in the fourth quarter. Vanguard Group Inc. now owns 237,459,756 shares of the company’s stock worth $34,030,358,000 after acquiring an additional 2,829,151 shares in the last quarter. State Street Corp raised its holdings in shares of Procter & Gamble by 1.0% in the 4th quarter. State Street Corp now owns 101,618,926 shares of the company’s stock worth $14,563,008,000 after acquiring an additional 984,102 shares during the last quarter. Geode Capital Management LLC lifted its position in Procter & Gamble by 3.3% in the 4th quarter. Geode Capital Management LLC now owns 62,647,882 shares of the company’s stock valued at $8,962,689,000 after acquiring an additional 1,974,556 shares in the last quarter. Norges Bank acquired a new position in Procter & Gamble during the 4th quarter valued at about $4,664,783,000. Finally, Price T Rowe Associates Inc. MD boosted its stake in Procter & Gamble by 3.8% during the 4th quarter. Price T Rowe Associates Inc. MD now owns 29,612,826 shares of the company’s stock valued at $4,243,815,000 after purchasing an additional 1,091,091 shares during the last quarter. Institutional investors and hedge funds own 65.77% of the company’s stock.

More Procter & Gamble News

Here are the key news stories impacting Procter & Gamble this week:

• Positive Sentiment: Procter & Gamble’s long dividend track record remains a key support for the stock, with the company having raised its payout for 70 consecutive years, reinforcing its status as a dependable income name. Article title
• Positive Sentiment: JPMorgan kept an overweight rating on PG while only trimming its price target to $162 from $164, signaling continued upside expectations from current levels. Article title
• Positive Sentiment: Some commentary says PG still screens as undervalued and could benefit from planned cuts to as many as 7,000 non-manufacturing roles, which may improve margins over time. Article title
• Neutral Sentiment: Erste Group slightly lowered its FY2026 and FY2027 earnings estimates, but the changes were minimal and its full-year FY2026 forecast still matches consensus. Article title
• Neutral Sentiment: UBS said consumer-staple companies likely had another “tricky” quarter, which suggests a challenging operating backdrop for PG and peers rather than a company-specific setback. Article title
• Negative Sentiment: The stock is also being pressured by a broader risk-off move and weakness in equities, including a selloff in growth/AI-related names that has pushed some investors back toward defensive stocks like PG. Article title

About Procter & Gamble

Procter & Gamble (NYSE: PG) is a multinational consumer goods company headquartered in Cincinnati, Ohio. Founded in 1837 by William Procter and James Gamble, P&G has grown into one of the world’s largest producers of branded consumer packaged goods. The company focuses on developing, manufacturing and marketing a broad portfolio of household and personal care products sold to consumers and retailers worldwide.

P&G’s product offering spans several core business categories, including Beauty, Grooming, Health Care, Fabric & Home Care, and Baby, Feminine & Family Care.